ARTICLE | Company News
Corixa submits Bexxar data to FDA
August 9, 2001 7:00 AM UTC
CRXA and partner GlaxoSmithKline (GSK; LSE:GSK) submitted data and analyses to the FDA to support its response to the agency's complete review letter regarding the companies' BLA for Bexxar. On March ...